Cargando…
Molecular mechanisms and design principles for promiscuous inhibitors to avoid drug resistance: Lessons learned from HIV‐1 protease inhibition
Molecular recognition is central to biology and ranges from highly selective to broadly promiscuous. The ability to modulate specificity at will is particularly important for drug development, and discovery of mechanisms contributing to binding specificity is crucial for our basic understanding of b...
Autores principales: | Shen, Yang, Radhakrishnan, Mala L., Tidor, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829108/ https://www.ncbi.nlm.nih.gov/pubmed/25410041 http://dx.doi.org/10.1002/prot.24730 |
Ejemplares similares
-
A printable hydrogel microarray for drug screening avoids false positives associated with promiscuous aggregating inhibitors
por: Mateen, Rabia, et al.
Publicado: (2018) -
Enhancing the promiscuity of a member of the Caspase protease family by rational design
por: Öhlknecht, Christoph, et al.
Publicado: (2020) -
Rational Approaches to
Improving Selectivity
in Drug Design
por: Huggins, David J., et al.
Publicado: (2012) -
Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
por: Mótyán, János András, et al.
Publicado: (2022) -
Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)
por: Mencher, Simon K, et al.
Publicado: (2005)